1.21
전일 마감가:
$1.27
열려 있는:
$1.28
하루 거래량:
1.05M
Relative Volume:
1.86
시가총액:
$117.57M
수익:
$10.59M
순이익/손실:
$-40.05M
주가수익비율:
-2.3087
EPS:
-0.5241
순현금흐름:
$-32.23M
1주 성능:
+3.42%
1개월 성능:
+4.31%
6개월 성능:
-16.55%
1년 성능:
+42.25%
Hyperfine Inc Stock (HYPR) Company Profile
명칭
Hyperfine Inc
전화
866-796-6767
주소
351 NEW WHITFIELD STREET, GUILFORD
Compare HYPR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
HYPR
Hyperfine Inc
|
1.21 | 123.40M | 10.59M | -40.05M | -32.23M | -0.5241 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | 개시 | Evercore ISI | Outperform |
| 2022-04-14 | 개시 | Wells Fargo | Overweight |
Hyperfine Inc 주식(HYPR)의 최신 뉴스
Lake Street raises Hyperfine stock price target on revenue growth outlook - Investing.com
Hyperfine Q4 2025 Financial Results & Swoop System Growth | March 2026News and Statistics - IndexBox
Hyperfine (HYPR) Q4 2025 Financial Results Conference Call Transcript - Bitget
Guilford medtech firm secures up to $40M in debt financing - Hartford Business Journal
B. Riley Raises Price Target on Hyperfine to $1.60 From $1.30, Keeps Buy Rating - marketscreener.com
Hyperfine reports net loss of USD 5.91M in Q4 2025 - Medical Buyer
Hyperfine Q4 2025 Earnings Call Transcript - MarketBeat
Hyperfine Reports Strong 2025 Growth, Launches Next-Gen Swoop MRI and Optive AI, Projects 55% Revenue Increase for 2026 - Minichart
Hyperfine Inc (HYPR) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Advances - Investing.com Canada
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results - The National Law Review
Hyperfine outlines 55% revenue growth target for 2026 while expanding Swoop MRI adoption across hospitals and neurology offices - MSN
Hyperfine Q4 Earnings Call Highlights - MarketBeat
Hyperfine reports Q4 EPS (6c) vs (14c) last year - TipRanks
Earnings call transcript: Hyperfine Q4 2025 beats expectations, stock rises - Investing.com
Hyperfine enters loan and security agreement with Horizon Technology FinanceSEC filing - marketscreener.com
HYPR: Q4 2025 revenue up 128% YoY; 2026 guidance targets 55% growth and margin expansion - TradingView
Hyperfine Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Hyperfine Secures $40 Million Term Loan Financing Agreement - TipRanks
Hyperfine (NASDAQ:HYPR) Issues Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
HYPERFINE ($HYPR) Releases Q4 2025 Earnings - Quiver Quantitative
HYPR: AI-powered portable MRI drives clinical access, growth, and strong financial performance - TradingView
HYPR: 2025 revenue rose 5.2% to $13.6M, net loss narrowed, and new Swoop® system launched - TradingView
Hyperfine, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Hyperfine (NASDAQ: HYPR) expands AI-powered portable brain MRI reach - Stock Titan
Hyperfine Q4 Loss Narrows, Revenue Rises; Issues Guidance - marketscreener.com
Hyperfine (NASDAQ: HYPR) adds $40M loan facility and over 1.0M stock warrants - Stock Titan
Hyperfine (HYPR) boosts Q4 growth, guides 55% higher 2026 revenue - Stock Titan
BRIEF-Hyperfine, Inc. Q4 EPS USD -0.06 - TradingView
Hyperfine, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
Hyperfine, Inc. announced that it has received $15 million in funding from Horizon Technology Finance Management, LLC - marketscreener.com
Hyperfine Inc (HYPR) Q4 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
Hyperfine Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
Press Release: Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 - 富途牛牛
Hyperfine Inc Stock (ISIN: US44917L1098) Gains Traction Amid Portable MRI Expansion - AD HOC NEWS
Hyperfine (HYPR) to Release Earnings on Wednesday - MarketBeat
EPS Watch: Is Hyperfine Inc affected by consumer sentimentEarnings Growth Report & Risk Managed Investment Signals - baoquankhu1.vn
Hyperfine Swoop® Portable MRI Presented by Lioness Medtech at Akutveckan 2026 - marketscreener.com
AI-powered portable MRI maker Hyperfine sets March 18 earnings call - Stock Titan
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 - marketscreener.com
Hyperfine (NASDAQ:HYPR) Stock Price Down 4.3%Here's Why - MarketBeat
Decliners Report: Will XIFR benefit from AI trendsWeekly Gains Summary & Verified Entry Point Detection - baoquankhu1.vn
Will Hyperfine Inc. stock continue dividend increasesJuly 2025 Analyst Calls & Consistent Profit Trade Alerts - mfd.ru
Patterns Watch: Can Hyperfine Inc be recession proofJuly 2025 Weekly Recap & Consistent Profit Alerts - baoquankhu1.vn
Form 4: TEISSEYRE THOMAS reports sale transactions in HYPR - Stock Titan
Can Hyperfine Inc. be recession proofTrade Ideas & Stepwise Trade Execution Plans - mfd.ru
Will Hyperfine Inc. stock benefit from infrastructure spendingTrade Volume Summary & Technical Pattern Alert System - mfd.ru
EV Market: Is Hyperfine Inc part of any major indexJuly 2025 Trade Ideas & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Hyperfine’s HYPR Stock: Can Portable MRI’s Under-the-Radar Disruptor Turn Volatility Into a Brea - AD HOC NEWS
Short Interest in Hyperfine, Inc. (NASDAQ:HYPR) Increases By 46.4% - MarketBeat
Analyst Calls: Does Hyperfine Inc have a sustainable dividendBond Market & Low Volatility Stock Recommendations - baoquankhu1.vn
Hyperfine’s portable MRI shows promise in detecting small strokes By Investing.com - Investing.com Australia
Hyperfine Inc (HYPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):